Simulations Plus Inc SLP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SLP is a good fit for your portfolio.
News
-
Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum
-
Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety
-
Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results
-
Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
-
Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date
-
QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus
-
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
-
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
Trading Information
- Previous Close Price
- $39.49
- Day Range
- $39.32–40.26
- 52-Week Range
- $32.69–52.69
- Bid/Ask
- $38.72 / $44.98
- Market Cap
- $794.31 Mil
- Volume/Avg
- 101,448 / 125,325
Key Statistics
- Price/Earnings (Normalized)
- 43.25
- Price/Sales
- 12.05
- Dividend Yield (Trailing)
- 0.60%
- Dividend Yield (Forward)
- 0.60%
- Total Yield
- 0.60%
Company Profile
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 197
- Website
- https://www.simulations-plus.com
Comparables
Valuation
|
Metric
|
SLP
|
SPOK
|
4554
|
|---|---|---|---|
Price/Earnings (Normalized) | 43.25 | 20.31 | 11.86 |
Price/Book Value | 4.39 | 1.97 | 0.76 |
Price/Sales | 12.05 | 2.28 | 0.77 |
Price/Cash Flow | 45.97 | 10.45 | 4.65 |
Price/Earnings
SLP
SPOK
4554
Financial Strength
|
Metric
|
SLP
|
SPOK
|
4554
|
|---|---|---|---|
Quick Ratio | 11.41 | 1.08 | 0.55 |
Current Ratio | 11.98 | 1.30 | 1.24 |
Interest Coverage | — | — | 58.74 |
Quick Ratio
SLP
SPOK
4554
Profitability
|
Metric
|
SLP
|
SPOK
|
4554
|
|---|---|---|---|
Return on Assets (Normalized) | 8.02% | 8.95% | 4.98% |
Return on Equity (Normalized) | 8.65% | 12.31% | 10.16% |
Return on Invested Capital (Normalized) | 6.03% | 11.02% | 6.17% |
Return on Assets
SLP
SPOK
4554
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Skfnwxyt | Rrrj | $36.7 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Jqrsrwljm | Qrcq | $31.1 Bil | |||
| Solventum Corp
SOLV
| — | Lcmmtsc | $10.0 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Cdxsnl | $9.2 Bil | |||
| HealthEquity Inc
HQY
| — | Ybxjzh | $7.0 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Bxmyw | $6.9 Bil | |||
| M3 Inc
MTHRF
| — | Bwzpdnt | $6.6 Bil | |||
| M3 Inc ADR
MTHRY
| — | Rlfvzw | $6.6 Bil | |||
| R1 RCM Inc
RCM
| — | Ppsdn | $5.5 Bil | |||
| Doximity Inc Class A
DOCS
| — | Zncdj | $5.2 Bil |